💨 Abstract

In the first quarter of 2025, Curis Inc., a drug developer based in Lexington, Massachusetts, reported a loss of $10.6 million, equating to $1.25 per share. The company generated revenue of $2.4 million. This news was generated by Automated Insights using data from Zacks Investment Research.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖